| |
| |
|
| Insider
Information: |
Basil Michelle L |
| Relationship: |
EVP and General Counsel |
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
32,272 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,967,410 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
32,272 |
|
|
| Total
Value |
$2,967,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.6
|
| Percentage
Gain/Loss : |
0.0%
|
 71.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP and General Counsel |
2023-10-20 |
32,272 |
2017-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-10-20 |
4 |
D |
$89.05 |
$17,543 |
D/D |
(197) |
32,272 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-18 |
4 |
D |
$83.34 |
$295,107 |
D/D |
(3,541) |
32,469 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-16 |
4 |
D |
$89.21 |
$39,788 |
D/D |
(446) |
36,010 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,205 |
36,456 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2023-05-12 |
4 |
D |
$88.16 |
$17,985 |
D/D |
(204) |
32,251 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-10-24 |
4 |
S |
$80.39 |
$14,470 |
D/D |
(180) |
32,455 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-09-19 |
4 |
AS |
$78.36 |
$897,065 |
D/D |
(11,448) |
32,635 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-09-19 |
4 |
OE |
$38.43 |
$365,743 |
D/D |
8,688 |
44,083 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-09-15 |
4 |
AS |
$77.76 |
$2,632,594 |
D/D |
(33,798) |
35,395 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-09-15 |
4 |
OE |
$38.43 |
$1,200,724 |
D/D |
28,558 |
69,193 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-06-13 |
4 |
S |
$62.60 |
$17,340 |
D/D |
(277) |
40,635 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$192,548 |
D/D |
(3,258) |
40,912 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,076 |
44,170 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2022-05-16 |
4 |
S |
$56.10 |
$10,996 |
D/D |
(196) |
38,094 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-10-25 |
4 |
S |
$71.93 |
$8,632 |
D/D |
(120) |
38,290 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$24,350 |
D/D |
(442) |
38,605 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$12,142 |
D/D |
(220) |
39,047 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
23,864 |
39,267 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$11,418 |
D/D |
(204) |
15,403 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2021-03-08 |
4 |
S |
$120.07 |
$46,227 |
D/D |
(385) |
15,607 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-10-23 |
4 |
S |
$106.58 |
$19,291 |
D/D |
(181) |
15,992 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-16 |
4 |
AS |
$90.32 |
$1,223,006 |
D/D |
(13,436) |
16,173 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-15 |
4 |
AS |
$87.71 |
$927,796 |
D/D |
(10,578) |
29,609 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-12 |
4 |
AS |
$89.29 |
$18,126 |
D/D |
(203) |
40,187 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP and General Counsel |
• • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,014 |
40,390 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
